Margaret West Comprehensive Breast Center: Exceeding the standards for superior breast screening and diagnostic services Dr. Landrieu has joined Dr. Patricia Turner, Director of Breast Imaging, at the Margaret West Comprehensive Breast Center this month. Having worked together for over 17 years in high volume breast practices, they have collectively interpreted over 1 million breast… Read more »
Posts By: Mae Bennett
West is 1 of 10 for ASCO Conquer Cancer Foundation Grant
West Cancer Center & Research Institute (WCCRI) was selected as 1 of 10 oncology practices in the country to receive a grant from ASCO’s Conquer Cancer Foundation to serve medically underserved populations in our community. West Cancer Center is committed to closing the gap in cancer care disparity in the Mid-South. Since 1979, West has spent over… Read more »
Survival After Robotic-Assisted Prostatectomy for Localized Prostate Cancer: An Epidemiologic Study.
Click here to read the full story. Survival After Robotic-Assisted Prostatectomy for Localized Prostate Cancer: An Epidemiologic Study. November 5, 2019 To determine the potential survival benefit associated with robotic-assisted laparoscopic prostatectomy (RALP) compared to open radical prostatectomy (ORP) for prostate cancer. RALP has become the dominant surgical approach for localized disease in… Read more »
Dr. Martin in Nepal
West Cancer Center’s Medical Oncologist, Dr. Michael Martin – living our mission to help cancer patients everywhere. Dr. Martin joined the American Society of Clinical Oncology (ASCO) and Health Volunteer Overseas (HVO) in Kathmandu, Nepal to bring new oncology technologies and treatments to physicians and provide hope for patients battling cancer. Our providers at West take… Read more »
Dr. Lee Schwartzberg on How Biosimilars Will Help Address Financial Toxicity
“We really believe that biosimilars line up as a value accretion for every constituency, whether it’s the patient, the practice, or the payer,” said Lee Schwartzberg, MD, FACP, executive director, West Cancer Center. Click here for full article & video interview. Transcript: OneOncology announced that its practices have begun administering the 2 cancer… Read more »
West is 1st center in the country to offer the 1st FDA-approved Mesothelioma treatment in more than 15 years
West Cancer Center is the first center in the country to offer the first FDA-approved Mesothelioma treatment in more than 15 years A clinical study showed that the NovoTTF-100L™ System in combination with chemotherapy may help people with malignant pleural mesothelioma extend their lives West Cancer Center is pleased to announce they have been… Read more »
Convinced that chemo patients shouldn’t be cold, too, teenagers create blankets
Maggie Spence said that when her mother, Dorchelle, was diagnosed with breast cancer two years ago, it took awhile for her to gather the strength to attend chemotherapy sessions with her. “I couldn’t stand the thought of seeing her in a weaker position than me,” Maggie, 16, admitted. But when the Lausanne Collegiate School student… Read more »
When I found my breast cancer, I hadn’t had a screening in four years. Don’t be like me
In 2016, I was diagnosed with Stage 1 breast cancer. And I was, on one level, lucky. Lucky that, after not bothering to get a mammogram since 2011, I didn’t discover a tumor that had spread to other parts of my body. “After four years of not being screened, that is a blessing,” said Keesha… Read more »
New pancreatic cancer treatment increases survival rates
Even with aggressive and skilled treatment, pancreatic cancer is often deadly. But, work by West Cancer Center’s Dr. Axel Grothey — in partnership with doctors at the Mayo Clinic — shows that a new treatment protocol offers better outcomes for patients with the disease. Research published in the Annals of Surgery details an approach used… Read more »
Collaboration between West Cancer Center and UTHSC Brings CAR T-Cell Therapy to the Mid-South
Patients with relapsed or refractory non-Hodgkin’s lymphoma and young adults with relapsed or refractory acute lymphoblastic leukemia now have access to a procedure called chimeric antigen receptor T-cell therapy, abbreviated as CAR-T. A collaboration between the physicians at the UTHSC Blood and Marrow Transplant Center and the clinical research team at West Cancer Center, supported… Read more »